Survival Outcomes of Patients With Borderline Resectable and Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Short-Course Chemoradiotherapy With Capecitabine-Based vs. Gemcitabine-Based Concurrent Chemotherapy

被引：0
|
作者：
Neibart, S. S. [1 ]
Mamidanna, S. [1 ]
Chundury, A. [1 ]
Sayan, M. [1 ]
Alexander, H. R. [2 ]
August, D. [2 ]
Berim, L. D. [3 ]
Boland, P. M. [3 ]
Grandhi, M. S.
Gulhati, P. [3 ]
Hochster, H. S. [3 ]
Kennedy, T. J. [2 ]
Langan, R. C. [2 ]
Spencer, K. [3 ]
Jabbour, S. K. [1 ]
机构：
[1] Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
[2] Rutgers Canc Inst New Jersey, Dept Surg Oncol, New Brunswick, NJ USA
[3] Rutgers Canc Inst New Jersey, Dept Med Oncol, New Brunswick, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2081
引用
收藏
页码：E64 / E64
页数：1
相关论文
共 50 条
  • [21] Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors
    Toshihiko Masui
    Ryuichiro Doi
    Yoshiya Kawaguchi
    Asahi Sato
    Kenzo Nakano
    Tatsuo Ito
    Takayuki Anazawa
    Kyoichi Takaori
    Shinji Uemoto
    Surgery Today, 2016, 46 : 1282 - 1289
  • [22] Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX , or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
    Ghaneh, Paula
    Palmer, Daniel
    Cicconi, Silvia
    Jackson, Richard
    Halloran, Christopher Michael
    Rawcliffe, Charlotte
    Sripadam, Rajaram
    Mukherjee, Somnath
    Soonawalla, Zahir
    Wadsley, Jonathan
    Al-Mukhtar, Ahmed
    Dickson, Euan
    Graham, Janet
    Jiao, Long
    Wasan, Harpreet S.
    Tait, Iain S.
    Prachalias, Andreas
    Ross, Paul
    Valle, Juan W.
    O'Reilly, Derek A.
    Al-Sarireh, Bilal
    Gwynne, Sarah
    Ahmed, Irfan
    Connolly, Kate
    Yim, Kein-Long
    Cunningham, David
    Armstrong, Thomas
    Archer, Caroline
    Roberts, Keith
    Ma, Yuk Ting
    Springfeld, Christoph
    Tjaden, Christine
    Hackert, Thilo
    Buchler, Markus W.
    Neoptolemos, John P.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 157 - 168
  • [23] Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study
    Suto, Hironobu
    Fuke, Takuro
    Matsukawa, Hiroyuki
    Ando, Yasuhisa
    Oshima, Minoru
    Nagao, Mina
    Takahashi, Shigeo
    Shibata, Toru
    Yamana, Hiroki
    Kamada, Hideki
    Kobara, Hideki
    Okuyama, Hiroyuki
    Kumamoto, Kensuke
    Okano, Keiichi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [24] Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer
    Wang, Bu-Hai
    Cao, Wen-Miao
    Yu, Jie
    Wang, Xiao-Lei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2129 - 2132
  • [25] Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric Cancer
    Badgwell, Brian
    Ikoma, Naruhiko
    Murphy, Mariela Blum
    Li, Jenny
    Wang, Xuemei
    Minsky, Bruce D.
    Estrella, Jeannelyn
    Mansfield, Paul
    Ajani, Jaffer
    Das, Prajnan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (02): : 423 - 431
  • [26] Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer
    Badgwell, Brian
    Das, Prajnan
    Ikoma, Naruhiko
    Blum, Mariela
    Li, Jenny
    Estrella, Jeannelyn
    Minsky, Bruce
    Mansfield, Paul F.
    Ajani, Jaffer
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S45 - S45
  • [27] SURGICAL OUTCOMES IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA AFTER NEOADJUVANT CHEMOTHERAPY AND FIDUCIAL TARGETED IGRT: AN INSTITUTIONAL EXPERIENCE
    Sharma, Manav
    Singh, Shailendra
    Rao, Bharat
    Kirichenko, Alexander
    Morrissey, Suzanne
    Mitre, Marcia
    Garg, Mrinal
    Kumar, Ujjala
    Kulkarni, Abhijit
    Monga, Dulabh
    Schiffman, Suzanne
    Williams, Harry K.
    Atkinson, Donald
    Lupetin, Anthony
    Dhawan, Manish
    Thakkar, Shyam
    GASTROENTEROLOGY, 2017, 152 (05) : S276 - S277
  • [28] Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Kondo, Naru
    Nakagawa, Naoya
    Takahashi, Shinya
    Sueda, Taijiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 37 - 47
  • [29] Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Naru Kondo
    Naoya Nakagawa
    Shinya Takahashi
    Taijiro Sueda
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 37 - 47
  • [30] Favorable Perioperative and Survival Outcomes After Resection of Borderline Resectable Pancreatic Cancer Treated With Neoadjuvant Stereotactic Radiation and Chemotherapy Compared With Upfront Pancreatectomy for Resectable Cancer
    Mellon, E. A.
    Strom, T.
    Hoffe, S. E.
    Frakes, J. M.
    Springett, G. M.
    Hodul, P. J.
    Malafa, M. P.
    Chuong, M. D.
    Shridhar, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S154 - S154
12345